Michael Ziegelasch

Klara Martinsson, Simon Åhammar, Alexandra Circiumaru, Bence Rethi, Michael Ziegelasch, Aase Hensvold, Alf Kastbom (2025)

Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjects JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, Vol. 11, Article 100317 (Article in journal)

Simon Åhammar, Klara Martinsson, Michael Ziegelasch, Alf Kastbom (2024)

Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain Scandinavian Journal of Rheumatology, Vol. 53, p. 118-122 (Article in journal)

Hans-Juergen Ziegelasch, Ralf Schiel, Thomas Ebert, Michael Ziegelasch (2022)

Caring for diabetic patients in Germany - what is going wrong? DIABETOLOGIE UND STOFFWECHSEL, Vol. 17, p. 377-381 (Article in journal)

Hilde Berner Hammer, Inger Marie Jensen Hansen, Pentti Järvinen, Marjatta Leirisalo-Repo, Michael Ziegelasch, Birte Agular, Lene Terslev (2021)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission Rheumatology: Advances in Practice, Vol. 5, Article rkab030 (Article in journal)

Helena Enocsson, Tanja Lukic, Michael Ziegelasch, Alf Kastbom (2021)

Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time Translational Research: The Journal of Laboratory and Clinical Medicine, Vol. 232, p. 142-149 (Article in journal)

Publications